Sellas Life Sciences Group Inc. (SLS)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Kriegsman	$6.13	250,000	Director	5,000	2014-01-22	Filing
Kriegsman	$7.00	200,000	Director	5,000	2014-01-17	Filing
Nisi	$6.90	200,000	Director	3,500	2014-01-17	Filing
Cytrx	$2.20	2,593,881	Large Shareholder	0	2010-12-29	Filing
Cytrx	$2.65	500,000	Large Shareholder	2,593,881	2010-12-22	Filing
Varanasi	$2.05	5,000	Officer	5,558	2010-07-19	Filing
Cytrx	$5.70	675,000	Large Shareholder	5,093,881	2010-03-26	Filing
Cytrx	$2.55	2,000,000	Large Shareholder	3,093,881	2010-06-30	Filing
Samarsky	$4.65	4,081	Officer	0	2010-03-31	Filing
Galliker	$5.54	15,000	Director	10,000	2010-03-26	Filing
Hillsberg	$5.66	25,000	Director	6,000	2010-03-26	Filing
Cytrx	$2.50	500,000	Large Shareholder	5,768,881	2009-09-23	Filing
Kriegsman	$3.13	8,990	Director	0	2009-08-19	Filing
Kriegsman	$4.19	1,723	Director	8,988	2009-07-02	Filing
Kriegsman	$4.53	1,170	Director	10,711	2009-07-01	Filing
Kriegsman	$4.45	2,900	Director	11,881	2009-06-30	Filing
Kriegsman	$4.65	1,800	Director	14,781	2009-06-29	Filing
Kriegsman	$4.55	4,600	Director	16,581	2009-06-26	Filing
Kriegsman	$4.64	1,500	Director	21,181	2009-06-25	Filing
Kriegsman	$4.69	600	Director	22,681	2009-06-24	Filing